Halozyme Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
CEOHelen I. Torley
CEOHelen I. Torley
Employees350
Employees350
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1998
Founded1998
Employees350
Employees350
HALO Key Statistics
Market cap6.65B
Market cap6.65B
Price-Earnings ratio14.28
Price-Earnings ratio14.28
Dividend yield—
Dividend yield—
Average volume4.35M
Average volume4.35M
High today$54.17
High today$54.17
Low today$53.33
Low today$53.33
Open price$53.73
Open price$53.73
Volume867.43K
Volume867.43K
52 Week high$70.51
52 Week high$70.51
52 Week low$42.01
52 Week low$42.01
HALO News
Simply Wall St 13h
High Growth Tech Stocks In The US Market With Promising PotentialThe U.S. stock market has recently experienced a surge, with the S&P 500 and Nasdaq Composite reaching new all-time highs following a robust June jobs report th...
Analyst ratings
56%
of 9 ratingsBuy
55.6%
Hold
33.3%
Sell
11.1%
People also own
Based on the portfolios of people who own HALO. This list is generated using Robinhood data, and it’s not a recommendation.